Veterinary Medicine Information website

Cevac MD Rispens concentrate and solvent for suspension for injection for chickens

Authorised
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
Download as PDF

Product identification

Medicine name:
Cevac MD Rispens concentrate and solvent for suspension for injection for chickens
Active substance:
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
Target species:
  • Chicken
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Marek's disease virus, serotype 1, strain CVI-988 (Rispens, cell-associated), Live
    5000.00
    plaque forming unit
    /
    1.00
    Dose
Pharmaceutical form:
  • Concentrate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Chicken
      • Meat and offal
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD03
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Spain
Package description:
  • 1 ampoule containing 1000 doses
  • 1 ampoule containing 2000 doses
  • 1 ampoule containing 4000 doses
  • bag containing 200 ml of solvent
  • bag containing 400 ml of solvent
  • bag containing 800 ml of solvent
  • bag containing 1000 ml of solvent
  • bag containing 1200 ml of solvent
  • bag containing 1600 ml of solvent

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Ceva Salud Animal S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Ceva-Phylaxia Zrt.
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 3906 ESP
Date of authorisation status change:
Reference member state:
  • Spain
Procedure number:
  • ES/V/0312/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Croatia
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 21/12/2023
Download
Spanish (PDF)
Published on: 27/03/2026
Download

Package Leaflet

English (PDF)
Published on: 21/12/2023
Download
Spanish (PDF)
Published on: 28/05/2025
Download

Labelling

English (PDF)
Published on: 21/12/2023
Download
Spanish (PDF)
Published on: 28/05/2025
Download

Combined File of all Documents

English (PDF)
Published on: 24/07/2025
Download

es-puar-cevac-md-rispens-es.pdf

Spanish (PDF)
Published on: 17/03/2023
Download